Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions
about
Stem cell therapy for heart failure: Ensuring regenerative proficiencyExosomes and Their Therapeutic Potentials of Stem CellsTranslational research of adult stem cell therapyStem cells: An eventual treatment option for heart diseasesReprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?Stem cell therapy and tissue engineering for correction of congenital heart diseaseProgramming and reprogramming a human heart cell"String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant resultsOrigin of cardiomyocytes in the adult heartIntrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysisThe myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages.Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled TrialPreserved Nephrogenesis Following Partial Nephrectomy in Early Neonates.Strategies and Challenges to Myocardial Replacement TherapyIntrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal ModelTelocytes and putative stem cells in ageing human heartHeart Failure in Pediatric Patients With Congenital Heart Disease.Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarctionNon-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury.Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue.c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart.Multimodal Hydrogel-Based Platform To Deliver and Monitor Cardiac Progenitor/Stem Cell Engraftment.Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical applicationStem cells and nanomaterials.The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Cardiac stem cell therapy for cardiac repair.Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction.Stem cell-based cell therapy for glomerulonephritisLaser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: initial results from a prospective phase I multicenter trial.Biomaterial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes.Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration.Preconditioning stem cells for in vivo delivery.Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation.Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies.A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogrammingStem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment.Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction modelmiR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction.
P2860
Q26750516-DD9EEC20-8B50-4A62-B594-CE5E556B0B89Q26771909-E115F483-38A7-4250-A703-500055E658DDQ26774565-E62B0002-6817-4958-951A-D9411097C31EQ26782194-C867F111-8B78-4DC9-8C98-26F28868CA26Q26800082-5D937394-D78D-44A7-9D69-762A36341399Q26801514-89C98D18-2CB3-4FBD-A147-1DCF23686493Q26823933-54697E55-50E9-45D4-A683-5B8CAE796562Q26859990-33197573-486B-4321-B564-A54F23180BD5Q27023325-3CA7B8A7-7B59-4037-B1A3-AF9C56EAA847Q27310275-E6DB79E3-1CD9-4442-8213-F74476273D30Q27325259-45D24B50-6B44-4442-87BC-B711023B7153Q27336487-95378CA9-3C9B-49AC-B361-D734B896351AQ27349423-6FBD056C-6873-4C38-A621-CC9A16566D5FQ28068007-C607F978-A202-4CDF-B996-E0A76A1E4FFAQ28550109-D2DD0B76-9ADB-4874-889E-A368FFEBADBEQ28652464-916E8AA1-37E8-4741-8C67-BBBAD648A001Q30235239-6D692079-88AA-4122-AE8E-A2E191F18833Q30729604-8ED7F667-4DAE-4191-BC16-458BC3F872B8Q30827483-50787BD9-D7B0-4471-9AC5-7FDACD2072D2Q30841694-C4FD8BDF-1EEF-4CBF-9CBD-F30339ACDB3DQ30843677-DBCDBBC6-CE52-409F-AE93-1AFD937C1BEDQ33578162-CE8C1A58-964B-4EC5-8507-490C85C2C9DAQ33612426-E4C79928-0A86-47D5-BF1E-1D6E908C5AD2Q33651561-4E3DAEE3-E91D-44E4-B9CD-CEF596F13BA2Q33659982-2C4448C2-D3DC-4448-9AE7-741AA77FF9BDQ33748399-CC05ED9D-6DAF-4158-9011-ECB52B8C98E8Q33749374-936C52FF-1453-45A1-B744-D75A8323B92BQ33798113-87257486-CEF7-42BE-BED4-A681E022D563Q33805069-A56A5BD7-CF77-4882-851C-2D0CDD1146AEQ33855567-DB3831FD-4FE0-45ED-95DB-91BDE24CF91EQ33870611-2708B129-B724-4AEE-9AB8-70735D0598D6Q33909634-AE80DC7B-45E7-4A5E-A441-780FF9C79D3DQ33998015-8BC212AB-22F2-42C3-BAA5-D86F1F8787CEQ34004811-6CF11FC8-C919-4281-A6BC-5E1B1B404093Q34039059-5A07FECE-F2DF-427C-8485-283E5A6A29E8Q34149206-6FD9DAB6-FC94-48D9-BC54-6D1911F1BEBBQ34408109-FAEA5097-63DD-4848-9841-089D73053AA9Q34441749-B703E243-2CCF-4BF5-A0AE-9609873219A5Q34622172-65D5C0E9-6618-41C9-BBA0-5F9CBD07DD53Q34684493-873212AB-E019-43AB-8B20-D8072A429A72
P2860
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cell therapy for heart failure ...... llenges, and future directions
@ast
Cell therapy for heart failure ...... llenges, and future directions
@en
Cell therapy for heart failure ...... llenges, and future directions
@nl
type
label
Cell therapy for heart failure ...... llenges, and future directions
@ast
Cell therapy for heart failure ...... llenges, and future directions
@en
Cell therapy for heart failure ...... llenges, and future directions
@nl
prefLabel
Cell therapy for heart failure ...... llenges, and future directions
@ast
Cell therapy for heart failure ...... llenges, and future directions
@en
Cell therapy for heart failure ...... llenges, and future directions
@nl
P2860
P3181
P1433
P1476
Cell therapy for heart failure ...... llenges, and future directions
@en
P2093
Roberto Bolli
Santosh K. Sanganalmath
P2860
P304
P3181
P356
10.1161/CIRCRESAHA.113.300219
P407
P577
2013-08-30T00:00:00Z